Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PennantPark Secures $1.9 Billion Across Senior Credit Funds, Highlighting Strong Investor Demand for Core Middle Market Lending
-
Freddie Mac Announces Tender Offer for Any and All of Certain STACR Notes
-
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Great Place To Work and Fortune Media Announce Best Workplaces by Industry
-
Transactions under Novonesis’ share buyback program
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
RedCloud Repays All Convertible Notes In Full
-
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephro
-
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
-
H2O Innovation Lama Filters Obtains NSF Certification
-
Finchb Brings a Simple Solana Wallet to the Web, Phones and Telegram
-
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
-
Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine
-
YYForce Applauds Tesla and Elon Musk on Commencing Manufacturing of Optimus Humanoid Robots
-
LQR House Expands Fusion Five’s AI Capabilities Through Supplemental Agreement for OpenAI GPT Models
-
Bonny Bark Bandit “Arwen” Steals 2026 AKC Virtual Trick Dog Competition
-
X9 Receives FDA Breakthrough Device Designation for Investigational Dialysis Cannulation System and Completes Second Clinical Study
-
Just 7% of the Uranium Delivered to U.S. Reactors Last Year Was U.S.-Origin. The Reactor Pipeline Is Still Moving.
-
Cast & Crew Names Suraj Arora to Lead Newly Formed Client Experience Organization
-
Virtru and Pexip Partner to Add Zero Trust Access Control to Video Meetings
-
SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
-
A 16% Month for Gold Miners Puts Grade, Costs and By-Products Back in Charge
-
Evolve Royalties Provides Update on Highland Valley Copper Mine Royalty
-
CPRS Week 2026 to focus on Building Trust Through Communication
-
Historic Youth Climate Trial Begins in Vancouver as 15 Young Canadians Confront Federal Government in Court Over Charter Right Violations
-
Q-Free and Carahsoft Partner to Power Sustainable Smart Cities with Safe and Efficient Transportation
-
TEN, Ltd. Announces Common Shares Dividend and Share Repurchase Authorization
-
BondBloxx XEMD Emerging Markets Bond ETF Surpasses $1 Billion in Assets, Celebrated at Cboe Closing Bell
-
Nano Dimension Announces Essemtec’s New U.S. Headquarters Amid Accelerating Revenue Growth and Strong Aerospace and Defense Demand
-
Neo Appoints Scott Stout as Chief Revenue Officer
-
TechWish Enables a Leading US-based Electricity & Natural Gas Player to Identify More Than $1.1 Million in Potential Vendor Overbilling Through AI-driven Contract Intelligence
-
Why a 1950 Defense Law Matters Again for Tungsten, Antimony and Titanium
-
“Beyond the Burn: The Next Degree” – New Global Consumer Research from Kalsec® Reveals Demand for Pepper and Packaging Precision
-
Disguise Announces New Yoshi Costumes Just in Time for Halloween
-
Endeavor Bancorp Reports Record Net Income of $2.1 Million for the Third Quarter of 2026; Tangible Book Value Increases to $15.46 and NIM Remains Strong at 4.41%
-
Namib Minerals Announces Expanded Milling Plant at How Mine Operating at Full Capacity, Ahead of Schedule
-
Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers
-
Braiin Targets USD 56.9 Billion CX Software Market with Agentic AI Expansion and Major Upgrade to RADIUS CX Platform
-
TechWish Enables a Leading US-based Electricity & Natural Gas Player to Identify More Than $1.1 Million in Potential Vendor Overbilling Through AI-driven Contract Intelligence
-
Trust Stamp signs Multi-Year Agreement to provide AI-Powered Identity Solutions for government programs in Nigeria, in a Multi-Year, Multi-Million-Dollar Engagement
-
Mentoring Leader Chronus Enters AI Coaching with Rumi
-
DigiCert Achieves Global ISO/IEC 27001:2022 Certification, Strengthening Security Assurance Across Its Intelligent Trust Platform
-
More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds
-
ZenaTech Targets Adjusted EBITDA Breakeven in 2027 Following 425% First-Half Revenue Growth
-
Game Your Game Launches “Explore Golf Course” Feature for GameGolf KZN AI™, Giving Golfers Course Insight and Social Play
-
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
-
CERo Therapeutics Announces Activation of Additional Clinical Trial Site for the CERTAIN-T Trial, its Ongoing Phase 1 Clinical Trial of CER-1236 in Hematological Cancers
